D0 FEATURED SESSION: The U.S. Human Papillomavirus Vaccination Program: Updates on Recent National Recommendations and Programmatic Issues

This featured session will provide an overview of current recommendations and programmatic issues regarding the use of human papillomavirus vaccines. Discussions will include postlicensure safety data for the quadrivalent vaccine and conducting HPV-related disease surveillance and assessing vaccination impact.
Tuesday, April 20, 2010: 11:00 AM-12:00 PM
Centennial Ballroom II/III/IV
Robin Curtis
11:00 AM
Introductory Remarks
11:20 AM
Post-Licensure Safety Data: Monitoring Two HPV Vaccine Products
Barbara Slade, MD, MS, Epidemiologist, Centers for Disease Control and Prevention
11:35 AM
11:50 AM
See more of: Submissions